Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sylvia Nanz"'
Publikováno v:
Cerebrovascular Diseases. 29:248-254
Background: After acute ischaemic stroke (AIS) or transient ischaemic attack (TIA), the detection of peripheral arterial disease (PAD) as a marker of generalized atherosclerosis may improve the risk stratification and prevention of future atherothrom
Autor:
Sylvia Nanz, Schwarz B
Publikováno v:
PharmacoEconomics German Research Articles. 4:31-45
Background Lower respiratory tract infections (LRTI) such as community-acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB) are frequent diseases associated with high morbidity and mortality. The use of antibiotics faces grow
Autor:
Schwarz B, Sylvia Nanz
Publikováno v:
PharmacoEconomics German Research Articles. 3:9-24
Atherosclerotic diseases represent the most important cause for mortality and morbidity worldwide. Antithrombotic drugs are used to prevent acute ischemic events in these patients. Clopidogrel has been proven to be a very effective strategy, although
Publikováno v:
PharmacoEconomics German Research Articles. 2:31-41
The CURE trial showed a 20 % risk reduction of suffering from stroke, myocardial infarction or cardiovascular death in patients with acute coronary syndrome without ST-segment elevation treated with clopidogrel on top of standard therapy including ac
Publikováno v:
PharmacoEconomics German Research Articles. 1:17-28
Publikováno v:
Geburtshilfe und Frauenheilkunde. 50:278-285
Although the efficacy of electronic foetal heart rate (FHR) monitoring and intermittent scalp blood sampling is well established, these methods still result in a considerable number of false positive and negative predictions. Consequently, methods, w